Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
ASCO 2024
Pharma
FDA expands label for AZ's Tagrisso in NSCLC indication
The FDA has signed off on Tagrisso to become the first targeted therapy for unresectable, stage 3 EGFRm non-small cell lung cancer.
Kevin Dunleavy
Sep 26, 2024 10:52am
Merck, AstraZeneca, Gilead: The race for supremacy in an ADC field
Aug 2, 2024 4:00pm
Bayer pharma commercial boss talks restructuring, oncology goals
Jul 10, 2024 9:36am
Despite J&J's full nod, FDA endorses Dizal's accelerated plan
Jun 26, 2024 11:08am
Inside ASCO 2024: Biggest data drops and the best exhibit booth
Jun 14, 2024 8:44am
Pfizer sees 8 blockbuster cancer drugs from each focus area
Jun 13, 2024 12:45pm
